Clinical therapeutic effects of trastuzumab in HER2-positive breast cancer patients: A protocol for systematic review and meta-analysis

BACKGROUND: Despite the developments in diagnosis and treatment of HER2-positive metastatic breast cancer, there is a high likelihood in the development of resistance to trastuzumab. In general, HER2-positive patients with deteriorated health face negative clinical outcomes. The present study is con...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Chuanming, Wang, Chuan, Yang, Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084074/
https://www.ncbi.nlm.nih.gov/pubmed/33907141
http://dx.doi.org/10.1097/MD.0000000000025685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084074/
https://www.ncbi.nlm.nih.gov/pubmed/33907141
http://dx.doi.org/10.1097/MD.0000000000025685

Ejemplares similares